Lung Cancer Considered

Follow Lung Cancer Considered
Share on
Copy link to clipboard

Dr. Jack West hosts Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.

IASLC


    • Aug 26, 2025 LATEST EPISODE
    • weekdays NEW EPISODES
    • 37m AVG DURATION
    • 335 EPISODES


    Search for episodes from Lung Cancer Considered with a specific topic:

    Latest episodes from Lung Cancer Considered

    IASLC - ALK Positive Summit

    Play Episode Listen Later Aug 26, 2025 38:16


    IASLC - ALK Positive Summit by IASLC

    LCC in Greek: Virtual Tumor Board - ALK NSCLC

    Play Episode Listen Later Aug 22, 2025 60:42


    LCC in Greek: Virtual Tumor Board - ALK NSCLC by IASLC

    Lung Cancer Considered--STK11 and KEAP1 as resistance mechanisms to immunotherapy

    Play Episode Listen Later Aug 19, 2025 53:26


    Lung Cancer Considered--STK11 and KEAP1 as resistance mechanisms to immunotherapy by IASLC

    LCC in Cantonese: Novel Treatment for Advanced EGFR Mutant Lung Cancer

    Play Episode Listen Later Aug 15, 2025 64:39


    LCC in Cantonese: Novel Treatment for Advanced EGFR Mutant Lung Cancer by IASLC

    FDA Approval: Zongertinib for HER2 Mutant NSCLC

    Play Episode Listen Later Aug 12, 2025 41:55


    FDA Approval: Zongertinib for HER2 Mutant NSCLC by IASLC

    LCC in Arabic: Arab Women's Voices in Thoracic Oncology

    Play Episode Listen Later Aug 8, 2025 33:30


    As part of IASLC's ongoing series of podcasts in world languages, Dr. Nagla Abdel Karim moderates a discussion in Arabic with Dr. Asrar AlAhmadi and Dr. Maya Khalil. The group discusses the journey and career development of Arabic women in the field of thoracic oncology.

    Artificial Intelligence (AI) and Lung Cancer Treatment Decisions

    Play Episode Listen Later Aug 5, 2025 45:33


    Artificial Intelligence (AI) and Lung Cancer Treatment Decisions by IASLC

    Artificial Intelligence (AI) and Lung Cancer Treatment Decisions

    Play Episode Listen Later Aug 5, 2025 45:33


    Artificial Intelligence (AI) and Lung Cancer Treatment Decisions by IASLC

    LCC in Romanian: Management of Unresectable, EGFR-mutated Stage III Lung Cancer in Romania

    Play Episode Listen Later Aug 2, 2025 47:08


    LCC in Romanian: Management of Unresectable, EGFR-mutated Stage III Lung Cancer in Romania by IASLC

    IASLC - Stigma

    Play Episode Listen Later Jul 29, 2025 57:13


    IASLC - Stigma by IASLC

    LCC in Japanese: ASCO 2025 Highlights

    Play Episode Listen Later Jul 25, 2025 34:11


    LCC in Japanese: ASCO 2025 Highlights by IASLC

    Preview: IASLC | ASCO 2025 North American Conference on Lung Cancer

    Play Episode Listen Later Jul 23, 2025 22:40


    On December 5, 2025, we will kick off the IASLC ASCO 2025 North America Conference on Lung Cancer. Guest include Dr. Ramesh Rengan, the Peter Wootton Professor and Chair of Radiation Oncology at the University of Washington and Senior Vice President of the Fred Hutchinson Cancer Center and Dr. Kristen Marrone, Associate Professor of Oncology and Director of the Medical Oncology and Hematology Fellowship Program at Johns Hopkins University.

    FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC

    Play Episode Listen Later Jul 18, 2025 45:33


    FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC by IASLC

    FDA Approval: Sunvozertinib for EGFR Exon 20

    Play Episode Listen Later Jul 15, 2025 41:03


    FDA Approval: Sunvozertinib for EGFR Exon 20 by IASLC

    LCC in Portuguese: Virtual Tumor Board - EGFR NSCLC

    Play Episode Listen Later Jul 11, 2025 46:33


    LCC in Portuguese: Virtual Tumor Board - EGFR NSCLC by IASLC

    IASLC_WCLC 2025 Preview

    Play Episode Listen Later Jul 8, 2025 45:13


    IASLC_WCLC 2025 Preview by IASLC

    Virtual Tumor Board: Resectable EGFR NSCLC

    Play Episode Listen Later Jul 1, 2025 39:29


    In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a Virtual Tumor Board case with Dr. Chunxia Su and Dr. Collin Blakely. The case explores resectable EGFR NSCLC.

    FDA Approval: Taletrectinib and ROS1 NSCLC

    Play Episode Listen Later Jun 24, 2025 29:20


    In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of taletrectinib, a next-generation ROS1 kinase inhibitor, for NSCLC with a ROS1 gene fusion. Dr. Enriqueta Felip and Dr. Jorge Nieva join the conversation to help review the data and offer help place this new agent in the proper perspective.

    IASLC - ASCO 2025 Highlights

    Play Episode Listen Later Jun 6, 2025 55:15


    ASCO 2025 Highlights Guests: Charu Aggarwal, MD, MPH Leslye M. Heisler Professor of Medicine Section Chief, Thoracic and Head & Neck Cancer Associate Director, Penn Center for Cancer Care Innovation (PC3I) University of Pennsylvania Patrick Forde, MBBCh Associate Professor Johns Hopkins University

    FDA Approval: Telisotuzumab Vedotin and MET-Positive NSCLC

    Play Episode Listen Later May 27, 2025 33:15


    In this episode, we will discuss the FDA approval of telisotuzumab vedotin, an antibody drug conjugate, for NSCLC with high c-MET expression. To help review the data and offer perspective on this new agent, I am joined by two expert thoracic oncologists. I want to welcome Dr. Mor Moskovitz, Head of the Thoracic Medical Oncology Service at Davidoff Cancer Center at the Rabin Medical Center in Petah Tikva, Israel.

    LCC in Korean: Lung Cancer Updates & Future Directions

    Play Episode Listen Later May 23, 2025 33:41


    LCC in Korean: Lung Cancer Updates & Future Directions by IASLC

    Global Advances and Persistent Disparities in Lung Cancer Treatment

    Play Episode Listen Later May 20, 2025 47:50


    Global Advances and Persistent Disparities in Lung Cancer Treatment by IASLC

    Dr. Bryant Lin Teaching My Cancer

    Play Episode Listen Later May 6, 2025 41:26


    Dr. Bryant Lin Teaching My Cancer by IASLC

    AACR 2025 Highlights

    Play Episode Listen Later May 2, 2025 52:03


    AACR 2025 Highlights by IASLC

    What You Should Know About RET-Positive NSCLC: Live from TexasLung25

    Play Episode Listen Later Apr 29, 2025 30:48


    In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion live from the Texas Lung Cancer Conference with Dr. Mihaela Aldea about the key information about RET-positive NSCLC, from diagnostic challenges to treatment selection. Join us in this lively discussion.

    Live from Texas Lung - Patient Education

    Play Episode Listen Later Apr 22, 2025 40:46


    Live from Texas Lung - Patient Education by IASLC

    ELCC 2025 Highlights

    Play Episode Listen Later Apr 6, 2025 43:04


    Guest: Dr. Corey Langer is the Director of Thoracic Oncology and Professor of Medicine at the Hospital of the University of Pennsylvania

    Lung Cancer Considered-Stigma

    Play Episode Listen Later Mar 16, 2025 57:13


    Lung Cancer Considered-Stigma by IASLC

    Virtual Tumor Board: Targeting Residual Disease

    Play Episode Listen Later Mar 16, 2025 49:11


    Virtual Tumor Board: Targeting Residual Disease by IASLC

    LCC in Korean: 2024 Lung Cancer Updates

    Play Episode Listen Later Mar 16, 2025 33:41


    LCC in Korean: 2024 Lung Cancer Updates by IASLC

    The Microbiome and Immunotherapy for Lung Cancer

    Play Episode Listen Later Mar 16, 2025 50:55


    The Microbiome and Immunotherapy for Lung Cancer by IASLC

    Live from TTLC25: Brain Metastasis

    Play Episode Listen Later Mar 16, 2025 19:11


    Live from TTLC25: Brain Metastasis by IASLC

    LCC in Mandarin: Virtual Tumor Board - EGFR NSCLC

    Play Episode Listen Later Mar 16, 2025 28:05


    LCC in Mandarin: Virtual Tumor Board - EGFR NSCLC by IASLC

    Lung Cancer Considered in Turkish

    Play Episode Listen Later Mar 16, 2025 56:03


    Host: Ece Cali Daylan, Assistant Professor of Medicine, Division of Oncology at Washington University School of Medicine Guest: Saadettin Kilickap Guest: Ozden Altundag

    LCC in Italian: Virtual Tumor Board - Resectable NSCLC

    Play Episode Listen Later Mar 16, 2025 50:54


    LCC in Italian: Virtual Tumor Board - Resectable NSCLC by IASLC

    Lung Cancer Considered in Hungarian

    Play Episode Listen Later Mar 15, 2025 61:15


    As part of IASLC's ongoing series of podcasts in world languages, Dr. Balazs Halmos moderates a discussion in Hungarian with Dr. Krisztina Bogos, Dr. Ferenc Rényi-Vámos and Dr. Zsolt Megyesfalvi. The podcast reviews recent advances in lung cancer screening, diagnosis and management with a particular focus on implementation in Hungary. Highlights of the discussion include novel staging and diagnostic tools, state-of-the-art biomarker testing, perioperative therapy and clinical trials access. Host: Balazs Halmos, MD, Director, Thoracic Oncology & Clinical Cancer Genomics, Montefiore Medical Park at Eastchester, Bronx, New York Guest: Ferenc Rényi-Vámos, MD, PhD, Thoracic Surgery, Semmelweis University and National Institute of Oncology, Budapest, Hungary Guest: Krisztina Bogos, MD, Thoracic Oncology National Koranyi Institute of Pulmonology, Budapest, Hungary Lung Cancer Research and Pathology Guest: Zsolt Megyesfalvi, MD, PhD, Semmelweis University and National Institute of Oncology, Budapest, Hungary and National Koranyi Institute of Pulmonology, Budapest, Hungary

    Thymus Talk: Unraveling Thymoma and Thymic Carcinoma

    Play Episode Listen Later Mar 15, 2025 45:11


    This episode of Lung Cancer Considered takes an in-depth look at thymoma and thymic carcinomas, both challenging diseases to treat with evolving new therapeutics. Join host Dr. Narjust Florez and guests, Dr. Claudia Proto and Dr. Kim Chul, for a discussion of these understudied and potentially poorly understood diseases.

    LCC in Cantonese: WCLC24 Highlights

    Play Episode Listen Later Mar 9, 2025 25:30


    The 2024 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research and celebrate IASLC's 50th anniversary. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2024 in world languages. In this episode, host Dr. Sally Lau moderates a discussion in Cantonese Chinese about highlights from the conference with Dr. David Lee and Dr. Molly Li.

    Virtual Tumor Board: Stage III ALK+ NSCLC

    Play Episode Listen Later Mar 5, 2025 48:32


    Virtual Tumor Board: Stage III ALK+ NSCLC by IASLC

    Live from TTLC25: Targeted Therapy in Early Stage NSCLC Debate

    Play Episode Listen Later Feb 28, 2025 25:28


    Live from TTLC25: Targeted Therapy in Early Stage NSCLC Debate by IASLC

    The Benefits of Patient Advocacy Groups

    Play Episode Listen Later Feb 24, 2025 30:07


    In this episode of Lung Cancer Considered, host Dr. Narjust Florez engages in a discussion with patient advocate Summer Farmen. Listen to the episode to learn about Summer's journey through diagnosis and treatment, and the importance of patient advocate groups. • Summer Farmen ALKtALK Program Coordinator Board Member, ALK Positive, Inc.

    Live from TTLC25: Targeted Therapy in SCLC

    Play Episode Listen Later Feb 20, 2025 29:22


    In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion on how small cell lung cancer continues to evolve with new treatment options and recent FDA approval. Listen to the episode to learn about the current standard of care and future therapies with a brief discussion about small cell transformation. Guest: Triparna Sen, MD Associate Professor Director, Lung Cancer PDX Program, Icahn School of Medicine at Mount Sinai Guest: Jacob Sands, MD Assistant Professor of Medicine, Harvard Medical School Lowe Cancer Center for Thoracic Oncology Dana Farber Cancer Institute

    Live from TTLC 2025: Mesothelioma and NUT Carcinoma

    Play Episode Listen Later Feb 20, 2025 44:47


    In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion of two of the most challenging thoracic malignancies – NUT carcinoma and mesothelioma. Listen to the episode to learn about the role of next-generation sequencing in diagnosis and treatment selection, as well as current and future targeted therapy in the management of both. Guests Melina Marmarelis, MD MSCE Assistant Professor Medical Director, UPenn Mesothelioma University of Pennsylvania Jia Luo, MD Medical Oncologist, Thoracic Oncology Program, Dana-Farber Cancer Institute Faculty, Brigham and Women's Hospital and Harvard Medical School

    LCC in Arabic: Chemo Immunotherapy in Metastatic NSCLC

    Play Episode Listen Later Feb 14, 2025 15:09


    Descriptions: As part of the IASLC's ongoing series of podcasts in world languages, Dr. Nagla Abdel Karim moderates a discussion in Arabic with Dr. Bashir Abu Aqeel and Dr. Fawzi Abu Rous. The group discusses chemoimmunotherapy in metastatic non-small cell lung cancer.

    Virtual Tumor Board: Treating EGFR NSCLC After TKI Resistance

    Play Episode Listen Later Feb 11, 2025 45:50


    In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a Virtual Tumor Board case involving drug resistance in EGFR mutant NSCLC. This discussion takes the listener through the treatment of EGFR mutant NSCLC after acquired resistance to osimertinib. Guest: Dr. Yasushi Goto from National Cancer Center, Japan in Tokyo Guest: Dr. Rachel Sanborn, the Earle A. Chiles Research Institute of the Providence Cancer Institute in Portland, Oregon

    LAURA Study (Part 2) - Radiation Oncology Perspective

    Play Episode Listen Later Feb 4, 2025 47:21


    This episode of Lung Cancer Considered covers the recent FDA approval of Osimertinib after chemo-radiation in EGFR positive NSCLC based on the LAURA trial which was presented at the 2024 ASCO Annual Meeting. Host Dr. Narjust Florez goes in depth with podcast guest Dr. Pamela Samson about the LAURA Trial and its implications for patients and clinicians. Guest: Dr. Pamela Samson is an assistant professor in the Department of Radiation Oncology at Washington University in St. Louis. Dr. Samson specializes in the care of thoracic malignancies and ways to deliver appropriate radiation therapy without compromising efficacy and diminishing toxicities.

    IASLC Lung Cancer Considered in German

    Play Episode Listen Later Jan 22, 2025 52:45


    Description: As part of IASLC's commitment to communicating in all world languages, this episode of Lung Cancer Considered is recorded in German and is part of our Virtual Tumor Board series. Host Professor Alessandra Curioni-Fontecedro moderates a discussion with two colleagues, who will discuss the dynamic topic of managing resectable stage III NSCLC. Host: Prof Alessandra Curioni-Fontecedro, MD, Head of Oncology, Cantonal Hospital Fribourg, Chair of Medical Oncology, University of Fribourg Guest: Prof. Isabelle Opitz, Professor of Thoracic Surgery and Director of the Department of Thoracic Surgery at University Hospital of Zurich, Chair of the Lung Cancer Center of Zurich, and the past President of the European Society of Thoracic Surgery. She received the IASLC Robert J Ginsberg Lectureship Award for Surgery at the 2022 World Conference on Lung Cancer Guest: Prof. Michael Thomas, Chefarzt of Dept of Thoracic Oncology at the Thoraxklinik Heidelberg, Germany.

    FDA Approval Zenocutuzumab For NRG1 Fusion Cancers

    Play Episode Listen Later Jan 21, 2025 20:29


    In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of zenocutuzumab for NSCLC with an NRG1 fusion. NRG1 fusions are rare but important events seen in many cancer types, including NSCLC. Zenocutuzumab is a HER2/HER3 bispecific antibody that showed clear efficacy in NSCLC and in pancreatic cancer that harbored an NRG1 fusion. Guest: Dr. Alison Schram, Assistant Attending Physician and Section Head of Oral Therapeutics in Early Drug Development at Memorial Sloan Kettering Cancer Center in New York

    ESMO Immuno-Oncology Congress 2024 Highlights

    Play Episode Listen Later Jan 13, 2025 45:46


    ESMO Immuno-Oncology Congress 2024 Highlights Description: In this episode of Lung Cancer Considered, host Dr. Narjust Florez and Dr. Alfredo Addeo discuss some of the data presented at The ESMO Immuno-Oncology Congress 2024, which took place in December 2024 in Geneva, Switzerland. Guest: Dr. Alfredo Addeo, Professor and Chief of Oncology, University Hospital of Geneva

    Lung Cancer in Mexico

    Play Episode Listen Later Jan 10, 2025 47:41


    En este episodio de Lung Cancer Considered, vamos a hablar sobre el cancer de pulmón en México. Tengo el placer de tener en este episodio dos doctores con mucha experiencia tratando y entendiendo las necesidades de los pacientes con cancer de pulmón en México. Este episodio es una introducción y esperamos tener conversaciones as profundas en el futuro. Bio: Tenemos al Dr. Jorge Alatorre, Oncology clínico con Alta especialidad en Tumores del Tórax (Cáncer de pulmón y Mesotelioma). Y es jefe del Servicio de Oncología Médica del Instituto Nacional de Enfermedades Respiratorias (INER). También ofrece consulta en el Centro Médico ABC Santa Fe y en ONCARE ubicados en la Ciudad de México Bio: Dr. Silviano Rios, Cirujano torácico de la ciudad de Monterrey en México. Atiende a sus pacientes en el Hospital Zambrano Hellion y TecSalud y se especializa en cirugía mínimamente invasiva.

    2025 Pan-Africa Conference on Lung Cancer Meeting Preview

    Play Episode Listen Later Dec 18, 2024 46:21


    Preview: 2025 Pan-Africa Lung Cancer Meeting The 2025 Pan-Africa Lung Cancer Conference will take place January 31 - February 1, 2025, in Accra, Ghana and represents the first IASLC multidisciplinary lung cancer conference in Sub-Saharan Africa. In this episode of Lung Cancer Considered, host Dr. Narjust Florez talks with the conference co-chairs about this groundbreaking meeting and what attendees will experience at the meeting. Guest: Dr. Chukwumere E. Nwogu is a Professor of Surgery at Roswell Park Cancer Institute and the University at Buffalo Jacobs School of Medicine & Biomedical Sciences Guest: Dr. Jane Sandra Afriyie-Mensah is a Senior Pulmonologist and a Distinguished Academic and Researcher, currently affiliated with the University of Ghana and Korle Bu Teaching Hospital. X: NA

    Claim Lung Cancer Considered

    In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

    Claim Cancel